Clark Kenneth A 4
4 · Summit Therapeutics Inc. · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Clark Kenneth A
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-11+200,000→ 200,000 totalExercise: $19.95Exp: 2034-10-11→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The option was granted on October 11, 2024. The shares underlying the option shall vest in four equal annual installments, subject to the reporting person continuing to serve as a member of the Strategic Advisory Committee of the Board, with the first installment occurring on October 11, 2025.
- [F2]Not applicable.